# Innate Pharma SA: Form 6-K, filed Jul 11, 2023

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2023-07-11
- Accepted by EDGAR: Jul 11, 2023, 06:00 ET
- Period: 2023-07-11
- Accession: 0001157523-23-001074
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000115752323001074/a53444554.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000115752323001074/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000115752323001074/a53444554.htm

Filed Jul 11, 2023.
Source: SEC EDGAR, the filing index for accession 0001157523-23-001074. Last ingested by Listed: Nov 5, 2026, 11:30 ET. No prices; not investment advice.